Millendo Therapeutics US, Inc.

ACTIVE

7000 Shoreline Ct Ste 275, 密歇根州韦恩县, 密歇根州, United StatesSubsidiary

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

75.0%

Phase 1

25.0%

Trial Status Distribution

Active, not recruiting

25.0%

Terminated

75.0%

Clinical Trials

Trials sponsored by this organization (4)

Nevanimibe HCl for the Treatment of Classic CAH

Phase 2

Terminated

interventional

Jul 201815 participants

A Multicenter Dose-Titration Open-Label Study of Nevanimibe Hydrochloride for the Treatment of Classic Congenital Adrenal Hyperplasia

Phase 1

Active, not recruiting

May 201824 participants

A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome

Phase 2

Terminated

interventional

Apr 20174 participants

MLE4901 vs. Placebo for the Treatment of PCOS

Phase 2

Terminated

interventional

Jul 201655 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations